Biology Department, Saint Louis University, Saint Louis, Missouri, USA.
Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, Missouri, USA.
J Bacteriol. 2019 Sep 20;201(20). doi: 10.1128/JB.00367-19. Print 2019 Oct 15.
, a leading cause of sepsis and meningitis in neonates, utilizes multiple virulence factors to survive and thrive within the human host during an infection. Unique among the pathogenic streptococci, uses a bifunctional enzyme encoded by a single gene () to synthesize glutathione (GSH), a major antioxidant in most aerobic organisms. Since can also import GSH, similar to all other pathogenic streptococcal species, the contribution of GSH synthesis to the pathogenesis of disease is not known. In the present study, deletion mutants were generated in strains representing three of the most prevalent clinical serotypes of and were compared against isogenic wild-type and knock-in strains. When cultured in a chemically defined medium under nonstress conditions, each mutant and its corresponding wild type had comparable growth rates, generation times, and growth yields. However, deletion mutants were found to be more sensitive than wild-type or knock-in strains to killing and growth inhibition by several different reactive oxygen species. Furthermore, deletion of in strain COH1 significantly attenuated virulence compared to the wild-type or knock-in strains in a mouse model of sepsis. Taken together, these data establish that GSH is a virulence factor important for resistance to oxidative stress and that GSH synthesis plays a crucial role in pathogenesis and further suggest that the inhibition of GSH synthesis may provide an opportunity for the development of novel therapies targeting disease. Approximately 10 to 30% of women are naturally and asymptomatically colonized by However, transmission of from mother to newborn during vaginal birth is a leading cause of neonatal meningitis. Although colonized mothers who are at risk for transmission to the newborn are treated with antibiotics prior to delivery, is becoming increasingly resistant to current antibiotic therapies, and new treatments are needed. This research reveals a critical stress resistance pathway, glutathione synthesis, that is utilized by and contributes to its pathogenesis. Understanding the role of this unique bifunctional glutathione synthesis enzyme in during sepsis may help elucidate why produces such an abundance of glutathione compared to other bacteria.
无乳链球菌是导致新生儿败血症和脑膜炎的主要原因之一,它在感染过程中利用多种毒力因子在人体宿主中生存和繁殖。与致病性链球菌不同的是,无乳链球菌利用单个基因编码的双功能酶()合成谷胱甘肽(GSH),GSH 是大多数需氧生物的主要抗氧化剂。由于无乳链球菌也可以像所有其他致病性链球菌一样导入 GSH,因此 GSH 合成对无乳链球菌疾病发病机制的贡献尚不清楚。在本研究中,我们针对三种最常见的无乳链球菌临床血清型生成了缺失突变体,并将其与相应的同源野生型和敲入菌株进行了比较。当在非应激条件下的化学定义培养基中培养时,每个突变体及其相应的野生型菌株的生长速度、世代时间和生长产量都相当。然而,与野生型或敲入菌株相比,无乳链球菌缺失突变体对几种不同活性氧的杀伤和生长抑制更为敏感。此外,与野生型或敲入菌株相比,无乳链球菌 COH1 株中的缺失显著降低了其在败血症小鼠模型中的毒力。总之,这些数据表明 GSH 是一种抵抗氧化应激的毒力因子,并且 GSH 合成在无乳链球菌发病机制中起着至关重要的作用,进一步表明抑制 GSH 合成可能为开发针对无乳链球菌疾病的新型治疗方法提供机会。大约 10%至 30%的女性自然无症状地被无乳链球菌定植。然而,阴道分娩时母亲向新生儿传播是导致新生儿脑膜炎的主要原因。尽管有传播风险的定植母亲在分娩前接受抗生素治疗,但无乳链球菌对当前抗生素治疗的耐药性日益增强,需要新的治疗方法。这项研究揭示了一种关键的应激抵抗途径,即谷胱甘肽合成,该途径被无乳链球菌利用并有助于其发病机制。了解这种独特的双功能谷胱甘肽合成酶在无乳链球菌败血症中的作用,可能有助于阐明为什么与其他细菌相比,无乳链球菌产生如此大量的谷胱甘肽。